Clinical Trial Update: Compassionate Use of Evinacumab

View source ↗

Summary

Evinacumab (brand Evkeeza) has gained marketing approval for use in pediatric homozygous familial hypercholesterolemia, as well as indications for severe hypert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysbetalipoproteinemia
• Homozygous Familial Hypercholesterolemia
• Hypertriglyceridemia

Drugs mentioned

• Evkeeza (evinacumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Pediatric Homozygous Familial Hypercholesterolemia (HoFH), Severe Hypertriglyceridemia (HTG) | Status: APPROVED_FOR_MARKETING